Are you Dr. Donnellan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 85 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
250 25th Ave N
Ste 100
Nashville, TN 37203Phone+1 615-986-7600Fax+1 615-986-7601
Summary
- Dr. William Donnellan, MD is an oncologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee, Georgia, and Alabama. He is affiliated with TriStar Centennial Medical Center and CHI Memorial.
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Alabama Medical CenterResidency, Internal Medicine, 2008 - 2011
- University of Alabama School of MedicineClass of 2008
Certifications & Licensure
- GA State Medical License 2020 - 2026
- TN State Medical License 2014 - 2025
- AL State Medical License 2009 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias Start of enrollment: 2018 Oct 29
Publications & Presentations
PubMed
- 2 citationsA phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.Sudhir Manda, Bertrand M Anz 3rd, Christopher Benton, E Randolph Broun, Habte A Yimer
Hematological Oncology. 2024-05-01 - 3 citationsFirst-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay
Clinical and Translational Science. 2024-03-01 - Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting.Minoo Battiwalla, Ju-Hsien Chao, Tonya Cox, Jose Carlos Cruz, William B Donnellan
Clinical Hematology International. 2024-01-01
Press Mentions
- Sarah Cannon to Present Latest Cancer Research Insights at 2019 American Society of Clinical Oncology’s Annual MeetingMay 30th, 2019